Login to Your Account



Awaiting Genasense Decision, Genta Gets $16M In Stock Sale

By Jennifer Boggs


Thursday, September 21, 2006
The pinchpenny public market is pushing more firms to take the route of Solexa Inc., which gained a pledge for $75 million in a stock equity financing from busy Azimuth Opportunity Ltd. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription